{
    "hands_on_practices": [
        {
            "introduction": "A fundamental task in evaluating granulomatous inflammation is the search for a causative agent. This first exercise challenges you to move beyond simple memorization of staining results and instead reason from first principles. By understanding the biochemical differences in the cell walls of various mycobacteria and the chemical logic behind different staining procedures, you can master the selection and interpretation of special stains like Ziehl–Neelsen and Fite–Faraco, a core skill in infectious disease pathology.",
            "id": "4376763",
            "problem": "A pathology service evaluates two tissue specimens from patients with granulomatous inflammation. Specimen $1$ is a cavitary pulmonary lesion with caseating granulomas, and Specimen $2$ is a dermal lesion with noncaseating granulomas and abundant foamy macrophages. The laboratory performs Ziehl–Neelsen staining and Fite–Faraco staining to investigate the presence of mycobacteria.\n\nUse the following fundamental base to reason about the expected staining results and the mechanistic basis for them:\n\n- Acid-fastness is defined as the ability of certain bacteria to retain the primary dye after exposure to a mineral acid or acid-alcohol decolorizer. This property is conferred by a cell wall rich in long-chain mycolic acids, which produce a hydrophobic barrier that traps phenolic dyes and resists removal by acid decolorization.\n- The Ziehl–Neelsen method uses hot carbol fuchsin followed by a strong acid-alcohol decolorizer and a counterstain, and standard tissue processing can dissolve cell wall lipids.\n- The Fite–Faraco method uses cold carbol fuchsin, protects cell wall lipids during deparaffinization with an oil-xylene mixture, and employs a milder decolorizer (for example, sulfuric acid at approximately $1\\%$), thereby better preserving weakly acid-fast bacteria whose mycolic acid content is more susceptible to extraction and strong decolorization.\n\nBased on these principles, which option best specifies the expected microscopic appearances of Mycobacterium tuberculosis and Mycobacterium leprae on Ziehl–Neelsen and Fite–Faraco stains in these specimens, and correctly rationalizes the staining differences in terms of mycolic acid content and stain chemistry?\n\nA. Specimen $1$ (Mycobacterium tuberculosis) shows numerous bright red, often beaded, slender rods in necrotic granulomas with Ziehl–Neelsen; Specimen $2$ (Mycobacterium leprae) is frequently faint or negative with Ziehl–Neelsen but shows red slender bacilli within foamy macrophages on Fite–Faraco. The difference arises because Mycobacterium leprae has relatively lower abundance and shorter-chain mycolic acids, making it weakly acid-fast and prone to lipid extraction; Fite–Faraco protects lipids and uses milder decolorization, enhancing retention of the primary dye.\n\nB. Both specimens stain equivalently with Ziehl–Neelsen and Fite–Faraco because acid-fastness depends solely on heating to drive dye entry; Mycobacterium leprae stains better on Ziehl–Neelsen than on Fite–Faraco since heat increases carbol fuchsin penetration, and decolorization strength does not affect acid-fast organisms.\n\nC. Acid-fastness in mycobacteria is due primarily to thick peptidoglycan rather than lipids; therefore Ziehl–Neelsen distinctly highlights Mycobacterium leprae and Mycobacterium tuberculosis equally, while Fite–Faraco adds no advantage. Differences in observed staining are due to bacterial size, not cell wall composition.\n\nD. Fite–Faraco uses harsher alcohol decolorization than Ziehl–Neelsen to preferentially reveal bacteria with very high mycolic acid content; thus Mycobacterium tuberculosis is more intensely stained on Fite–Faraco, while Mycobacterium leprae is typically negative on both methods.\n\nE. Ziehl–Neelsen counterstain imparts red color to acid-fast organisms via a silver impregnation step, so both Mycobacterium tuberculosis and Mycobacterium leprae appear black on Fite–Faraco and blue on Ziehl–Neelsen; the differing colors are unrelated to mycolic acids and instead reflect capsule presence versus absence.",
            "solution": "### Derivation of Solution\n\n1.  **Identification of Aetiological Agents**: Based on the classic clinicopathological findings, Specimen $1$ (cavitary pulmonary lesion with caseation) is indicative of an infection by *Mycobacterium tuberculosis*. Specimen $2$ (dermal lesion with noncaseating granulomas and foamy macrophages, i.e., Virchow cells) is indicative of lepromatous leprosy, caused by *Mycobacterium leprae*.\n\n2.  **Application of Principles to *Mycobacterium tuberculosis* (Specimen $1$)**:\n    -   *M. tuberculosis* possesses a cell wall with a high concentration of long-chain mycolic acids, making it strongly acid-fast.\n    -   The Ziehl–Neelsen (ZN) method is designed for such organisms. The application of heat (`hot carbol fuchsin`) facilitates the penetration of the primary dye (carbol fuchsin) through the dense, waxy cell wall.\n    -   Once the dye is in the cytoplasm, the robust mycolic acid layer prevents it from being washed out by the `strong acid-alcohol decolorizer`.\n    -   Consequently, *M. tuberculosis* will retain the red/pink color of the carbol fuchsin, appearing as bright red rods against a blue or green counterstained background. The Fite–Faraco (FF) stain would also be positive, but ZN is the standard and highly effective method.\n\n3.  **Application of Principles to *Mycobacterium leprae* (Specimen $2$)**:\n    -   *M. leprae* has a cell wall with a comparatively lower content of mycolic acids, which are also more susceptible to extraction during tissue processing. This renders it weakly acid-fast.\n    -   When using the ZN method, two issues arise. First, standard deparaffinization can `dissolve cell wall lipids`, compromising the already weaker acid-fast property. Second, the `strong acid-alcohol decolorizer` is too harsh for the less robust mycolic acid layer of *M. leprae*, leading to removal of the primary dye. The result is often a faint or negative staining result with ZN.\n    -   The Fite–Faraco (FF) method is specifically modified to address these issues. It `protects cell wall lipids` using an oil-xylene mixture, preventing their loss during deparaffinization. It also employs a `milder decolorizer` (e.g., approx. $1\\%$ sulfuric acid), which is weak enough that *M. leprae* can resist it and retain the carbol fuchsin.\n    -   Therefore, *M. leprae* is expected to be visualized effectively with the FF stain, appearing as red rods, typically in large aggregates (globi) within the cytoplasm of foamy macrophages.\n\n4.  **Conclusion**: Specimen $1$ (*M. tuberculosis*) will stain strongly positive (red) with the ZN stain. Specimen $2$ (*M. leprae*) will stain poorly or negatively with the ZN stain but will stain positive (red) with the FF stain. The difference is attributable to the robust, high-content mycolic acid wall of *M. tuberculosis* versus the fragile, lower-content mycolic acid wall of *M. leprae*, and the corresponding suitability of the strong ZN versus the gentle FF staining procedures.\n\n### Evaluation of Options\n\n**A. Specimen $1$ (Mycobacterium tuberculosis) shows numerous bright red, often beaded, slender rods in necrotic granulomas with Ziehl–Neelsen; Specimen $2$ (Mycobacterium leprae) is frequently faint or negative with Ziehl–Neelsen but shows red slender bacilli within foamy macrophages on Fite–Faraco. The difference arises because Mycobacterium leprae has relatively lower abundance and shorter-chain mycolic acids, making it weakly acid-fast and prone to lipid extraction; Fite–Faraco protects lipids and uses milder decolorization, enhancing retention of the primary dye.**\n-   This option accurately describes the expected staining results for both organisms with both stains. It correctly identifies *M. tuberculosis* as ZN-positive and *M. leprae* as ZN-negative/faint but FF-positive. Crucially, it provides the correct mechanistic rationale: the weaker acid-fastness of *M. leprae* due to its mycolic acid composition and the specific modifications of the FF stain (lipid protection, mild decolorization) that compensate for this weakness.\n-   **Verdict: Correct.**\n\n**B. Both specimens stain equivalently with Ziehl–Neelsen and Fite–Faraco because acid-fastness depends solely on heating to drive dye entry; Mycobacterium leprae stains better on Ziehl–Neelsen than on Fite–Faraco since heat increases carbol fuchsin penetration, and decolorization strength does not affect acid-fast organisms.**\n-   This option makes several false claims. The organisms do not stain equivalently. Acid-fastness depends critically on resistance to decolorization, not just dye entry. *M. leprae* stains better with FF, not ZN. Decolorization strength is a fundamentally important variable that distinguishes strongly from weakly acid-fast organisms.\n-   **Verdict: Incorrect.**\n\n**C. Acid-fastness in mycobacteria is due primarily to thick peptidoglycan rather than lipids; therefore Ziehl–Neelsen distinctly highlights Mycobacterium leprae and Mycobacterium tuberculosis equally, while Fite–Faraco adds no advantage. Differences in observed staining are due to bacterial size, not cell wall composition.**\n-   This option incorrectly attributes acid-fastness to peptidoglycan instead of mycolic acids (lipids). It incorrectly claims equal staining with ZN and that FF offers no advantage. The differences are fundamentally due to cell wall composition, not bacterial size.\n-   **Verdict: Incorrect.**\n\n**D. Fite–Faraco uses harsher alcohol decolorization than Ziehl–Neelsen to preferentially reveal bacteria with very high mycolic acid content; thus Mycobacterium tuberculosis is more intensely stained on Fite–Faraco, while Mycobacterium leprae is typically negative on both methods.**\n-   This option incorrectly claims that the FF decolorizer is harsher; the problem statement and established protocols confirm it is milder. Consequently, the conclusion that *M. tuberculosis* stains more intensely on FF for this reason is flawed. The claim that *M. leprae* is negative on both is also false, as FF is the stain of choice for its demonstration.\n-   **Verdict: Incorrect.**\n\n**E. Ziehl–Neelsen counterstain imparts red color to acid-fast organisms via a silver impregnation step, so both Mycobacterium tuberculosis and Mycobacterium leprae appear black on Fite–Faraco and blue on Ziehl–Neelsen; the differing colors are unrelated to mycolic acids and instead reflect capsule presence versus absence.**\n-   This option is a compendium of errors. The primary stain (carbol fuchsin), not the counterstain, imparts the red color. ZN and FF are not silver impregnation methods and do not produce black-staining organisms. Acid-fast organisms appear red (from carbol fuchsin), not blue, on ZN. The mechanism is directly related to mycolic acids, not a capsule.\n-   **Verdict: Incorrect.**",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "While identifying an organism is conclusive, pathologists frequently face granulomas where special stains are negative. This creates a critical diagnostic dilemma, often boiling down to distinguishing sarcoidosis from an occult infection. This practice immerses you in this realistic scenario, forcing you to synthesize clinical, radiological, and histological clues while appreciating the diagnostic limitations of your tools, thereby honing the crucial skill of making a diagnosis of exclusion.",
            "id": "4376707",
            "problem": "A surgical pathologist receives a transbronchial lung biopsy from a patient aged $38$ years with dyspnea, dry cough, and chest imaging showing bilateral hilar lymphadenopathy with perilymphatic micronodules. Histologic evaluation demonstrates multiple, discrete, well-formed granulomas composed of epithelioid histiocytes and multinucleated giant cells with minimal surrounding lymphocytes, distributed along bronchovascular bundles and interlobular septa. Necrosis is absent. Occasional stellate inclusions consistent with so-called asteroid bodies and laminated calcified inclusions consistent with Schaumann bodies are present within giant cells. Ziehl–Neelsen staining for Acid-Fast Bacilli (AFB) and Grocott Methenamine Silver (GMS) staining for fungi are negative on multiple deeper levels. Tissue has been submitted for mycobacterial and fungal cultures; results are pending. A serum Angiotensin-Converting Enzyme (ACE) level is mildly elevated. Polymerase Chain Reaction (PCR) for mycobacterial DNA on formalin-fixed paraffin-embedded tissue is not performed.\n\nStarting from fundamental definitions of granulomas as organized aggregates of activated macrophages driven in many settings by T-helper 1 (Th1) immune responses, and using well-established principles about histologic patterns and the sensitivity and specificity of ancillary studies, which of the following statements most appropriately distinguishes sarcoid-like granulomas from infectious granulomas while acknowledging overlaps and diagnostic pitfalls?\n\nA. The presence of asteroid bodies and Schaumann bodies and the absence of necrosis conclusively establish sarcoidosis and obviate the need for microbial cultures.\n\nB. Necrosis within granulomas always indicates infection; therefore, if AFB and GMS stains are negative, infection can be excluded.\n\nC. A pattern of tight, “naked” nonnecrotizing granulomas with perilymphatic distribution in lung, coupled with negative AFB and GMS stains on adequately sampled tissue, favors sarcoidosis; however, mycobacterial and fungal cultures and, when appropriate, PCR may still be warranted because special stains have limited sensitivity and noninfectious and infectious causes can overlap.\n\nD. Demonstration of organisms by GMS or AFB within even a single granuloma is insufficient to diagnose infection; if the majority of granulomas lack organisms, sarcoidosis remains the most likely diagnosis.\n\nE. PCR positivity for mycobacterial DNA in formalin-fixed tissue always indicates active infection and should override histologic and culture findings when they are discordant.",
            "solution": "### Solution Derivation\n\nThe central task is to distinguish sarcoidosis from infectious granulomatous disease, recognizing that sarcoidosis is a diagnosis of exclusion. The provided vignette is highly suggestive of sarcoidosis, but infection must be reasonably ruled out.\n\n1.  **Analysis of Findings Suggesting Sarcoidosis:**\n    *   **Clinical/Radiologic:** The combination of a young adult patient with respiratory symptoms and bilateral hilar lymphadenopathy with a perilymphatic pattern of nodules is highly characteristic of sarcoidosis.\n    *   **Histologic:** The pattern of well-demarcated, \"tight\" granulomas with a scant lymphocytic infiltrate (\"naked\" granulomas) in a perilymphatic distribution is a classic histologic hallmark of sarcoidosis. Necrosis is characteristically absent. While not specific, asteroid and Schaumann bodies are famously associated with sarcoidosis.\n    *   **Laboratory:** A mildly elevated serum ACE level, while having low sensitivity and specificity, is a supportive finding.\n\n2.  **Analysis of Findings Regarding Infection:**\n    *   **The Rule-Out Principle:** The most critical differential diagnosis for non-necrotizing granulomas is an infectious etiology, particularly mycobacteria (e.g., *Mycobacterium tuberculosis*) and fungi (e.g., *Histoplasma capsulatum*, *Coccidioides immitis*). Atypical presentations of these infections can mimic sarcoidosis histologically. Therefore, a diagnosis of sarcoidosis requires that infection has been reasonably excluded.\n    *   **Interpretation of Special Stains (AFB, GMS):** These histochemical stains are used to visualize microorganisms directly within the tissue. Their specificity is very high; a definitively identified organism is diagnostic. However, their sensitivity is poor. The organism load in granulomatous inflammation can be very low (paucibacillary), especially in tissue samples. For example, the sensitivity of the AFB stain for *M. tuberculosis* in tissue biopsies can be as low as $20-40\\%$. Performing the stains on \"multiple deeper levels\" is the correct procedure to maximize the chance of finding a rare organism, but a negative result cannot definitively exclude infection.\n    *   **Role of Cultures:** Microbiologic culture is generally more sensitive than special stains and is considered a gold standard for confirming many infections. For slow-growing organisms like mycobacteria, results can take several weeks. A positive culture is definitive for infection. A negative culture provides stronger evidence against infection than negative stains, but is still not $100\\%$ sensitive.\n    *   **Role of PCR:** Molecular tests like PCR can detect microbial DNA with high sensitivity, often exceeding that of culture. They are also much faster. However, a positive PCR can indicate the presence of DNA from non-viable organisms and must be interpreted in the clinical context. False positives from contamination and false negatives from inhibitors or low target DNA can occur.\n\n3.  **Synthesis:** The constellation of findings in this case strongly favors sarcoidosis. However, the core principle of sarcoidosis being a diagnosis of exclusion, combined with the known low sensitivity of special stains for organisms, means that negative AFB and GMS stains are insufficient to conclusively rule out an infectious etiology. The appropriate diagnostic approach is to consider all the evidence together, acknowledge the limitations of the initial tests, and pursue more sensitive tests like culture (which has been done) and, in some cases, PCR to fully exclude mimics before finalizing a diagnosis and initiating therapy (e.g., corticosteroids for sarcoidosis, which could be disastrous in an untreated infection).\n\n### Option-by-Option Analysis\n\n*   **A. The presence of asteroid bodies and Schaumann bodies and the absence of necrosis conclusively establish sarcoidosis and obviate the need for microbial cultures.**\n    *   **Analysis:** This statement is incorrect. Asteroid bodies and Schaumann bodies are non-specific findings that can be observed in other granulomatous conditions, including infections like tuberculosis. The absence of necrosis also does not rule out infection. Therefore, these features are not \"conclusive.\" Because sarcoidosis is a diagnosis of exclusion, and special stains have low sensitivity, microbial cultures are essential for reasonably ruling out infection. To state that cultures are \"obviated\" is medically incorrect.\n    *   **Verdict:** **Incorrect**.\n\n*   **B. Necrosis within granulomas always indicates infection; therefore, if AFB and GMS stains are negative, infection can be excluded.**\n    *   **Analysis:** This statement is flawed in two ways. First, necrosis does not *always* indicate infection; certain non-infectious autoimmune conditions (e.g., granulomatosis with polyangiitis) are characterized by necrotizing granulomas. Second, the conclusion is a logical fallacy. The claim that negative stains can \"exclude\" infection is false, due to the low sensitivity of these stains, regardless of the presence or absence of necrosis.\n    *   **Verdict:** **Incorrect**.\n\n*   **C. A pattern of tight, “naked” nonnecrotizing granulomas with perilymphatic distribution in lung, coupled with negative AFB and GMS stains on adequately sampled tissue, favors sarcoidosis; however, mycobacterial and fungal cultures and, when appropriate, PCR may still be warranted because special stains have limited sensitivity and noninfectious and infectious causes can overlap.**\n    *   **Analysis:** This statement is a precise and accurate summary of the modern approach to diagnosing sarcoidosis. It correctly identifies the histologic pattern that \"favors sarcoidosis.\" It correctly qualifies this by stating it is not definitive. Most importantly, it provides the correct rationale for why further testing is necessary: the \"limited sensitivity\" of special stains and the \"overlap\" between sarcoidosis and its infectious mimics. This acknowledges the central diagnostic pitfall and describes the appropriate subsequent steps (cultures, PCR).\n    *   **Verdict:** **Correct**.\n\n*   **D. Demonstration of organisms by GMS or AFB within even a single granuloma is insufficient to diagnose infection; if the majority of granulomas lack organisms, sarcoidosis remains the most likely diagnosis.**\n    *   **Analysis:** This statement is fundamentally wrong. The specificity of GMS and AFB stains is extremely high. The unequivocal identification of even a single microorganism consistent with a pathogen (e.g., a yeast or a mycobacterium) in the proper clinical and histologic context is sufficient to diagnose an infectious process. The presence of an organism dictates the diagnosis and overrides the non-specific histologic pattern. The concept of a \"majority rule\" for granulomas is not a valid principle in pathology.\n    *   **Verdict:** **Incorrect**.\n\n*   **E. PCR positivity for mycobacterial DNA in formalin-fixed tissue always indicates active infection and should override histologic and culture findings when they are discordant.**\n    *   **Analysis:** This statement is overly absolute. PCR is a powerful tool but not infallible. A positive result does not \"always\" indicate active infection, as it can detect DNA from dead organisms. Furthermore, it should not automatically \"override\" all other data. A discordant result (e.g., positive PCR but positive fungal culture) requires careful clinicopathologic correlation to resolve, not a rigid rule of one test trumping all others. The risk of lab contamination leading to false-positive PCR results is also a significant consideration.\n    *   **Verdict:** **Incorrect**.",
            "answer": "$$\\boxed{C}$$"
        },
        {
            "introduction": "The previous exercise highlighted the uncertainty inherent in interpreting tests with imperfect sensitivity. This final practice allows you to quantify that uncertainty using the principles of Bayesian reasoning. By calculating how a test result alters the probability of disease, you will gain a profound understanding of how a test's utility is inextricably linked to the pre-test clinical suspicion, transforming your diagnostic approach from a qualitative guess to a quantitative, evidence-based assessment.",
            "id": "4376721",
            "problem": "A surgical pathology service is evaluating small tissue biopsies from patients with granulomatous inflammation to determine whether Mycobacterium tuberculosis infection is present. For detection of mycobacteria in granulomatous tissues, the laboratory has three modalities with the following performance characteristics, derived from validation studies using fresh tissue for culture and formalin-fixed, paraffin-embedded sections for histology and Polymerase Chain Reaction (PCR):\n\n- Mycobacterial culture: sensitivity $80\\%$, specificity $99.5\\%$.\n- PCR for mycobacterial DNA: sensitivity $70\\%$, specificity $95\\%$.\n- Histology (Hematoxylin and Eosin (H&E) showing necrotizing granulomas without demonstration of organisms): sensitivity $70\\%$, specificity $65\\%$.\n\nConsider two patients with granulomatous inflammation on biopsy:\n\n- Patient H has a high pretest probability of tuberculosis based on epidemiology, imaging, and clinical features: $70\\%$.\n- Patient L has a low pretest probability of tuberculosis based on clinical context and epidemiology: $10\\%$.\n\nAssume test results are conditionally independent given disease status, and interpret each modality as a single binary test (positive/negative) according to the above definitions. Which option most accurately compares how these tests’ sensitivity and specificity influence post-test probability, and justifies test selection according to pretest probability in these two patients?\n\nA. In Patient H ($70\\%$ pretest), a negative culture lowers the probability of tuberculosis to below $20\\%$; in Patient L ($10\\%$ pretest), a positive histology alone raises the probability above $70\\%$.\n\nB. In Patient H, a negative PCR lowers the probability to approximately $25\\%$; in Patient L, a positive culture yields a probability above $90\\%$.\n\nC. In Patient H, a negative histology lowers the probability below $30\\%$; in Patient L, a positive PCR yields a probability around $60\\%$.\n\nD. In Patient H, a negative culture still leaves the probability above $30\\%$; in Patient L, a positive culture yields a probability above $90\\%$.\n\nE. In Patient H, a single negative PCR rules out tuberculosis (probability below $5\\%$); in Patient L, a positive histology yields a probability around $50\\%$.",
            "solution": "## Solution Derivation\n\nThe core of this problem is the application of Bayes' theorem to calculate the post-test probability of disease. Let $D$ be the event that a patient has tuberculosis, and let $T^+$ and $T^-$ be the events of a positive and negative test result, respectively. The pretest probability is $P(D)$.\n\nThe post-test probability given a positive test, $P(D|T^+)$, is:\n$$ P(D|T^+) = \\frac{P(T^+|D) P(D)}{P(T^+|D) P(D) + P(T^+|D^c) P(D^c)} $$\nIn terms of sensitivity ($Sens$) and specificity ($Spec$):\n$$ P(D|T^+) = \\frac{Sens \\cdot P(D)}{Sens \\cdot P(D) + (1 - Spec) \\cdot (1 - P(D))} $$\n\nThe post-test probability given a negative test, $P(D|T^-)$, is:\n$$ P(D|T^-) = \\frac{P(T^-|D) P(D)}{P(T^-|D) P(D) + P(T^-|D^c) P(D^c)} $$\nIn terms of sensitivity and specificity:\n$$ P(D|T^-) = \\frac{(1 - Sens) \\cdot P(D)}{(1 - Sens) \\cdot P(D) + Spec \\cdot (1 - P(D))} $$\n\nWe will now apply these formulas to the specific statements in each option.\n\n**Given Data:**\n- Culture: $Sens_C = 0.8$, $Spec_C = 0.995$\n- PCR: $Sens_P = 0.7$, $Spec_P = 0.95$\n- Histology: $Sens_H = 0.7$, $Spec_H = 0.65$\n- Patient H: $P_H(D) = 0.7$, so $1 - P_H(D) = 0.3$\n- Patient L: $P_L(D) = 0.1$, so $1 - P_L(D) = 0.9$\n\n### Option-by-Option Analysis\n\n**A. In Patient H ($70\\%$ pretest), a negative culture lowers the probability of tuberculosis to below $20\\%$; in Patient L ($10\\%$ pretest), a positive histology alone raises the probability above $70\\%$.**\n\n- **First claim (Patient H, negative culture):** We calculate $P_H(D|T_C^-)$.\n  $$ P_H(D|T_C^-) = \\frac{(1 - Sens_C) \\cdot P_H(D)}{(1 - Sens_C) \\cdot P_H(D) + Spec_C \\cdot (1 - P_H(D))} $$\n  $$ P_H(D|T_C^-) = \\frac{(1 - 0.8) \\cdot 0.7}{(1 - 0.8) \\cdot 0.7 + 0.995 \\cdot 0.3} = \\frac{0.2 \\cdot 0.7}{0.14 + 0.2985} = \\frac{0.14}{0.4385} \\approx 0.3193 $$\n  The post-test probability is approximately $31.9\\%$. The claim is that it is \"below $20\\%$\". This is false.\n\n- **Second claim (Patient L, positive histology):** We calculate $P_L(D|T_H^+)$.\n  $$ P_L(D|T_H^+) = \\frac{Sens_H \\cdot P_L(D)}{Sens_H \\cdot P_L(D) + (1 - Spec_H) \\cdot (1 - P_L(D))} $$\n  $$ P_L(D|T_H^+) = \\frac{0.7 \\cdot 0.1}{0.7 \\cdot 0.1 + (1 - 0.65) \\cdot 0.9} = \\frac{0.07}{0.07 + 0.35 \\cdot 0.9} = \\frac{0.07}{0.07 + 0.315} = \\frac{0.07}{0.385} \\approx 0.1818 $$\n  The post-test probability is approximately $18.2\\%$. The claim is that it is \"above $70\\%$\". This is also false.\n\n**Verdict for A: Incorrect.** Both claims are factually incorrect based on calculation.\n\n**B. In Patient H, a negative PCR lowers the probability to approximately $25\\%$; in Patient L, a positive culture yields a probability above $90\\%$.**\n\n- **First claim (Patient H, negative PCR):** We calculate $P_H(D|T_P^-)$.\n  $$ P_H(D|T_P^-) = \\frac{(1 - Sens_P) \\cdot P_H(D)}{(1 - Sens_P) \\cdot P_H(D) + Spec_P \\cdot (1 - P_H(D))} $$\n  $$ P_H(D|T_P^-) = \\frac{(1 - 0.7) \\cdot 0.7}{(1 - 0.7) \\cdot 0.7 + 0.95 \\cdot 0.3} = \\frac{0.3 \\cdot 0.7}{0.21 + 0.285} = \\frac{0.21}{0.495} \\approx 0.4242 $$\n  The post-test probability is approximately $42.4\\%$. The claim is \"approximately $25\\%$\". This is false.\n\n- **Second claim (Patient L, positive culture):** We will calculate $P_L(D|T_C^+)$, although the option is already disproven.\n  $$ P_L(D|T_C^+) = \\frac{Sens_C \\cdot P_L(D)}{Sens_C \\cdot P_L(D) + (1 - Spec_C) \\cdot (1 - P_L(D))} $$\n  $$ P_L(D|T_C^+) = \\frac{0.8 \\cdot 0.1}{0.8 \\cdot 0.1 + (1 - 0.995) \\cdot 0.9} = \\frac{0.08}{0.08 + 0.005 \\cdot 0.9} = \\frac{0.08}{0.08 + 0.0045} = \\frac{0.08}{0.0845} \\approx 0.9467 $$\n  The post-test probability is approximately $94.7\\%$. The claim \"above $90\\%$\" is true. However, since the first claim is false, the option as a whole is incorrect.\n\n**Verdict for B: Incorrect.** The first claim is false.\n\n**C. In Patient H, a negative histology lowers the probability below $30\\%$; in Patient L, a positive PCR yields a probability around $60\\%$.**\n\n- **First claim (Patient H, negative histology):** We calculate $P_H(D|T_H^-)$.\n  $$ P_H(D|T_H^-) = \\frac{(1 - Sens_H) \\cdot P_H(D)}{(1 - Sens_H) \\cdot P_H(D) + Spec_H \\cdot (1 - P_H(D))} $$\n  $$ P_H(D|T_H^-) = \\frac{(1 - 0.7) \\cdot 0.7}{(1 - 0.7) \\cdot 0.7 + 0.65 \\cdot 0.3} = \\frac{0.3 \\cdot 0.7}{0.21 + 0.195} = \\frac{0.21}{0.405} \\approx 0.5185 $$\n  The post-test probability is approximately $51.9\\%$. The claim is \"below $30\\%$\". This is false.\n\n- **Second claim (Patient L, positive PCR):** We calculate $P_L(D|T_P^+)$.\n  $$ P_L(D|T_P^+) = \\frac{Sens_P \\cdot P_L(D)}{Sens_P \\cdot P_L(D) + (1 - Spec_P) \\cdot (1 - P_L(D))} $$\n  $$ P_L(D|T_P^+) = \\frac{0.7 \\cdot 0.1}{0.7 \\cdot 0.1 + (1 - 0.95) \\cdot 0.9} = \\frac{0.07}{0.07 + 0.05 \\cdot 0.9} = \\frac{0.07}{0.07 + 0.045} = \\frac{0.07}{0.115} \\approx 0.6087 $$\n  The post-test probability is approximately $60.9\\%$. The claim \"around $60\\%$\" is true. However, since the first claim is false, the option as a whole is incorrect.\n\n**Verdict for C: Incorrect.** The first claim is false.\n\n**D. In Patient H, a negative culture still leaves the probability above $30\\%$; in Patient L, a positive culture yields a probability above $90\\%$.**\n\n- **First claim (Patient H, negative culture):** We calculate $P_H(D|T_C^-)$. This was already calculated for option A.\n  $$ P_H(D|T_C^-) \\approx 0.3193 $$\n  The post-test probability is $31.93\\%$. The claim is \"above $30\\%$\". This is true.\n\n- **Second claim (Patient L, positive culture):** We calculate $P_L(D|T_C^+)$. This was already calculated for option B.\n  $$ P_L(D|T_C^+) \\approx 0.9467 $$\n  The post-test probability is $94.67\\%$. The claim is \"above $90\\%$\". This is also true.\n\nBoth claims are correct. This option correctly demonstrates that for a high pretest probability patient, even a negative result from the best available test (culture sensitivity is $80\\%$) cannot confidently rule out the disease. For a low pretest probability patient, a positive result from the most specific test (culture specificity is $99.5\\%$) is extremely effective at ruling in the disease.\n\n**Verdict for D: Correct.** Both claims are quantitatively accurate and illustrate key principles of diagnostic testing.\n\n**E. In Patient H, a single negative PCR rules out tuberculosis (probability below $5\\%$); in Patient L, a positive histology yields a probability around $50\\%$.**\n\n- **First claim (Patient H, negative PCR):** We calculate $P_H(D|T_P^-)$. This was already calculated for option B.\n  $$ P_H(D|T_P^-) \\approx 0.4242 $$\n  The post-test probability is $42.42\\%$. The claim is \"below $5\\%$\", which implies ruling out the disease. This is false. A post-test probability of $42.42\\%$ is still very high.\n\n- **Second claim (Patient L, positive histology):** We calculate $P_L(D|T_H^+)$. This was already calculated for option A.\n  $$ P_L(D|T_H^+) \\approx 0.1818 $$\n  The post-test probability is $18.18\\%$. The claim is \"around $50\\%$\". This is false.\n\n**Verdict for E: Incorrect.** Both claims are factually incorrect based on calculation.",
            "answer": "$$\\boxed{D}$$"
        }
    ]
}